Puma Biotechnology (PBYI) Net Income towards Common Stockholders (2010 - 2026)
Puma Biotechnology's Net Income towards Common Stockholders was $8.19 million in Q2 2026, up 39.9% from $5.86 million a year earlier.
Powered by 
Analysis
Puma Biotechnology (PBYI) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Puma Biotechnology's Net Income towards Common Stockholders was $26.64 million through Jun 30, 2026, down 45.0% year-over-year; for FY2025, it was $31.11 million, up 2.8% from FY2024.
- In earlier years, Net Income towards Common Stockholders was $30.28 million in FY2024 (+40.2%), $21.59 million in FY2023, $2,000 in FY2022 and -$29.13 million in FY2021.
- Quarterly Net Income towards Common Stockholders has moved between -$44.67 million (Q3 2021) and $20.32 million (Q3 2024) over five years.
- Compared with a year earlier, Net Income towards Common Stockholders was higher in three of the last five quarters, with growth averaging 52.2%.
- Per Business Quant data, PBYI's Net Income towards Common Stockholders in the three quarters before Q2 2026 was -$3.8 million (Q1 2026), $13.41 million (Q4 2025) and $8.84 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Puma Biotechnology | 485.99 Mn | 98.62 Mn | 44.03 Mn | 8.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.19 Mn |
| Mar 31, 2026 | -3.80 Mn |
| Dec 31, 2025 | 13.41 Mn |
| Sep 30, 2025 | 8.84 Mn |
| Jun 30, 2025 | 5.86 Mn |
| Mar 31, 2025 | 2.97 Mn |
| Dec 31, 2024 | 19.31 Mn |
| Sep 30, 2024 | 20.32 Mn |
| Jun 30, 2024 | -4.53 Mn |
| Mar 31, 2024 | -4.82 Mn |
| Dec 31, 2023 | 12.27 Mn |
| Sep 30, 2023 | 5.80 Mn |
| Jun 30, 2023 | 2.13 Mn |
| Mar 31, 2023 | 1.40 Mn |
| Dec 31, 2022 | -5.61 Mn |
| Sep 30, 2022 | -360,000.00 |
| Jun 30, 2022 | 9.37 Mn |
| Mar 31, 2022 | -3.40 Mn |
| Dec 31, 2021 | 4.22 Mn |
| Sep 30, 2021 | -44.67 Mn |
API Access
Puma Biotechnology Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();